TipRanks
CanaQuest Medical Corp. (CANQF)
OTHER OTC:CANQF
US Market
CANQF
CanaQuest Medical
RESEARCH TOOLSreports

CanaQuest Medical (CANQF) Ratios

4 Followers

CanaQuest Medical Ratios

CANQF's free cash flow for Q3 2024 was C$0.99. For the 2024 fiscal year, CANQF's free cash flow was decreased by C$ and operating cash flow was C$-14.39. See a summary of the company’s cash flow.
Ratios
TTM
Mar 24Mar 23Mar 22Mar 21
Liquidity Ratios
Current Ratio
 0.16 0.16 0.10 0.07 0.02
Quick Ratio
 0.16 0.16 0.10 0.07 0.02
Cash Ratio
 <0.01 <0.01 <0.01 0.02 <0.01
Solvency Ratio
 -1.03 -1.03 -0.72 -0.78 -0.29
Operating Cash Flow Ratio
 -0.21 -0.21 -0.43 -0.25 -0.10
Short-Term Operating Cash Flow Coverage
 -0.73 -0.73 -0.77 -0.55 -0.35
Net Current Asset Value
C$ -1.51MC$ -1.11MC$ -1.03MC$ -706.94KC$ -662.75K
Leverage Ratios
Debt-to-Assets Ratio
 1.75 1.75 4.51 4.95 8.66
Debt-to-Equity Ratio
 -0.34 -0.34 -0.63 -0.50 -0.31
Debt-to-Capital Ratio
 -0.51 -0.51 -1.71 -1.01 -0.45
Long-Term Debt-to-Capital Ratio
 0.00 0.00 0.00 0.00 0.00
Financial Leverage Ratio
 -0.19 -0.19 -0.14 -0.10 -0.04
Debt Service Coverage Ratio
 -3.05 -3.05 -1.12 -1.56 -0.86
Interest Coverage Ratio
 -27.20 -27.20 -18.37 -30.18 -15.74
Debt to Market Cap
 168.94 0.18 0.17 0.06 0.08
Interest Debt Per Share
 0.03 0.02 0.03 0.02 0.01
Net Debt to EBITDA
 -0.29 -0.29 -0.82 -0.58 -1.08
Profitability Margins
Gross Profit Margin
39.85%39.85%0.00%0.00%100.00%
EBIT Margin
-3893.46%-3893.40%0.00%0.00%-19301.12%
EBITDA Margin
-3833.31%-3833.25%0.00%0.00%-18870.45%
Operating Profit Margin
-4027.17%-4027.11%0.00%0.00%-21551.45%
Pretax Profit Margin
-4093.13%-4093.07%0.00%0.00%-20670.50%
Net Profit Margin
-4093.13%-4093.07%0.00%0.00%-20670.50%
Continuous Operations Profit Margin
-4093.13%-4093.07%0.00%0.00%-20670.50%
Net Income Per EBT
100.00%100.00%100.00%100.00%100.00%
EBT Per EBIT
101.64%101.64%97.10%96.85%95.91%
Return on Assets (ROA)
-644.89%-644.89%-590.60%-855.41%-871.77%
Return on Equity (ROE)
131.32%125.22%82.69%86.95%31.09%
Return on Capital Employed (ROCE)
123.21%123.21%85.16%89.78%32.41%
Return on Invested Capital (ROIC)
186.55%186.56%230.68%180.86%46.90%
Return on Tangible Assets
-644.89%-644.89%-590.60%-855.41%-871.77%
Earnings Yield
-62226.33%-65.33%-22.40%-9.64%-7.72%
Efficiency Ratios
Receivables Turnover
 1.46 1.46 0.00 0.00 0.13
Payables Turnover
 0.00 0.00 0.00 0.00 0.00
Inventory Turnover
 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
 13.64 13.64 0.00 0.00 0.08
Asset Turnover
 0.16 0.16 0.00 0.00 0.04
Working Capital Turnover Ratio
 -0.03 -0.03 0.00 0.00 >-0.01
Cash Conversion Cycle
 250.38 250.38 0.00 0.00 2.79K
Days of Sales Outstanding
 250.38 250.38 0.00 0.00 2.79K
Days of Inventory Outstanding
 0.00 0.00 0.00 0.00 0.00
Days of Payables Outstanding
 0.00 0.00 0.00 0.00 0.00
Operating Cycle
 250.38 250.38 0.00 0.00 2.79K
Cash Flow Ratios
Operating Cash Flow Per Share
 -0.02 -0.01 -0.02 >-0.01 >-0.01
Free Cash Flow Per Share
 -0.02 -0.01 -0.02 >-0.01 >-0.01
CapEx Per Share
 0.00 0.00 <0.01 <0.01 <0.01
Free Cash Flow to Operating Cash Flow
 1.00 1.00 1.01 1.07 1.02
Dividend Paid and CapEx Coverage Ratio
 0.00 0.00 -162.72 -14.81 -48.37
Capital Expenditure Coverage Ratio
 0.00 0.00 -162.72 -14.81 -48.37
Operating Cash Flow Coverage Ratio
 -0.73 -0.73 -0.77 -0.55 -0.35
Operating Cash Flow to Sales Ratio
 -8.07 -8.07 0.00 0.00 -71.07
Free Cash Flow Yield
-12269.28%-12.88%-13.21%-3.29%-2.71%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 >-0.01 -1.53 -4.46 -10.38 -12.95
Price-to-Sales (P/S) Ratio
 0.07 62.65 0.00 0.00 2.68K
Price-to-Book (P/B) Ratio
 >-0.01 -1.92 -3.69 -9.02 -4.03
Price-to-Free Cash Flow (P/FCF) Ratio
 >-0.01 -7.76 -7.57 -30.42 -36.90
Price-to-Operating Cash Flow Ratio
 >-0.01 -7.76 -7.62 -32.47 -37.66
Price-to-Earnings Growth (PEG) Ratio
 <0.01 -0.02 -0.11 -0.05 0.17
Price-to-Fair Value
 >-0.01 -1.92 -3.69 -9.02 -4.03
Enterprise Value Multiple
 -0.29 -1.92 -5.68 -11.42 -15.26
Enterprise Value
 512.89K 2.50M 4.35M 6.53M 2.82M
EV to EBITDA
 -0.29 -1.92 -5.68 -11.42 -15.26
EV to Sales
 11.16 73.75 0.00 0.00 2.88K
EV to Free Cash Flow
 -1.38 -9.14 -8.86 -32.03 -39.71
EV to Operating Cash Flow
 -1.38 -9.14 -8.91 -34.19 -40.53
Tangible Book Value Per Share
 -0.07 -0.05 -0.05 -0.03 -0.03
Shareholders’ Equity Per Share
 -0.07 -0.05 -0.05 -0.03 -0.03
Tax and Other Ratios
Effective Tax Rate
 0.00 0.00 0.00 0.00 0.00
Revenue Per Share
 <0.01 <0.01 0.00 0.00 <0.01
Net Income Per Share
 -0.09 -0.07 -0.04 -0.03 -0.01
Tax Burden
 1.00 1.00 1.00 1.00 1.00
Interest Burden
 1.05 1.05 1.08 1.04 1.07
Research & Development to Revenue
 1.23 1.23 0.00 0.00 4.43
SG&A to Revenue
 39.44 0.00 0.00 0.00 0.00
Stock-Based Compensation to Revenue
 0.00 0.00 0.00 0.00 0.00
Income Quality
 0.20 0.20 4.03 0.32 0.34
Currency in CAD